Datasets:
jarrydmartinx
/
support2

Dataset card Data Studio Files
xet
Community
age
float64
18
102
sex
stringclasses
2 values
hospdead
int64
0
1
slos
int64
3
343
dzgroup
stringclasses
8 values
dzclass
stringclasses
4 values
num.co
int64
0
9
edu
float64
0
31
⌀
income
stringclasses
4 values
scoma
float64
0
100
⌀
charges
float64
1.17k
1.44M
⌀
totcst
float64
0
633k
⌀
totmcst
float64
-102.72
711k
⌀
avtisst
float64
1
83
⌀
race
stringclasses
5 values
sps
float64
0.2
99.2
⌀
aps
float64
0
143
⌀
surv2m
float64
0
0.97
⌀
surv6m
float64
0
0.95
⌀
hday
int64
1
148
diabetes
int64
0
1
dementia
int64
0
1
ca
stringclasses
3 values
prg2m
float64
0
1
⌀
prg6m
float64
0
1
⌀
dnr
stringclasses
3 values
dnrday
float64
-88
285
⌀
meanbp
float64
0
195
⌀
wblc
float64
0
200
⌀
hrt
float64
0
300
⌀
resp
float64
0
90
⌀
temp
float64
31.7
41.7
⌀
pafi
float64
12
890
⌀
alb
float64
0.4
29
⌀
bili
float64
0.1
63
⌀
crea
float64
0.1
21.5
⌀
sod
float64
110
181
⌀
ph
float64
6.83
7.77
⌀
glucose
float64
0
1.09k
⌀
bun
float64
1
300
⌀
urine
float64
0
9k
⌀
adlp
float64
0
7
⌀
adls
float64
0
7
⌀
sfdm2
stringclasses
5 values
adlsc
float64
0
7.07
event_times
int64
3
2.03k
event_indicators
int64
0
1
68.112
female
0
25
Lung Cancer
Cancer
5
null
null
9
25,699
18,062.3438
22,461.6875
11.25
white
34.09375
28
0.197998
0.017998
1
0
0
metastatic
0.4
0.1
dnr after sadm
6
79
100
70
22
37.5
319
3.799805
1
1.299805
142
7.479492
84
21
null
null
null
<2 mo. follow-up
5.183594
27
1
68.67096
female
0
37
Coma
Coma
2
12
under $11k
44
100,640
66,801.3125
76,272.625
33.5
white
21.296875
40
0.32196
0.25
21
1
0
yes
0.6
0.4
no dnr
37
77
5
60
20
36.5
null
2
7.899414
0.899902
126
null
289
11
2,606
null
6
adl>=4 (>=5 if sur)
6
86
1
67.97797
female
1
5
CHF
COPD/CHF/Cirrhosis
1
8
null
37
68,460
43,711.4062
50,218.5
44
white
19.796875
32
0.689941
0.523926
18
0
0
no
0.75
0.6
no dnr
5
122
6.799805
195
38
38.39844
176.65625
2.799805
0.599976
0.799927
135
7.359375
99
11
1,565
null
null
<2 mo. follow-up
2.545898
5
1
59.73999
male
0
10
Lung Cancer
Cancer
2
12
$25-$50k
0
8,042
6,030.7617
7,824.15625
13.5
white
30.5
17
0.375977
0.087997
1
0
0
metastatic
0.1
0
dnr after sadm
1
136
18.898438
111
8
39.69531
148
3
0.699951
1.099854
146
7.489258
139
7
1,366
null
6
<2 mo. follow-up
6
12
1
69.383
female
1
112
ARF/MOSF w/Sepsis
ARF/MOSF
0
4
under $11k
0
435,766
293,525
354,347.25
27.75
hispanic
30
35
0.563965
0.451965
140
0
0
no
0.9
0.9
dnr after sadm
109
73
6.099609
76
24
35
null
3.299805
1.599854
1.5
143
null
45
33
null
null
0
adl>=4 (>=5 if sur)
0
112
1
78.51294
female
0
21
ARF/MOSF w/Sepsis
ARF/MOSF
0
null
null
37
30,168
20,644.1094
25,320.375
31
white
33.195313
48
0.367981
0.25
1
0
0
no
0.5
0.2
dnr after sadm
3
64
12.599609
120
32
36.5
240
2.399902
0.5
5.299805
130
7.339844
162
69
1,079
null
null
<2 mo. follow-up
3.983887
58
1
69.16595
female
0
15
COPD
COPD/CHF/Cirrhosis
3
12
under $11k
0
31,257
20,410.9219
24,307.25
24.666656
white
34.695313
49
0.492981
0.290955
7
0
0
no
0.8
0.8
no dnr
15
116
6.899414
114
8
36.19531
136
3
1.099854
2
144
7.40918
206
28
4,115
0
2
SIP>=30
2
376
1
84.27899
female
0
54
ARF/MOSF w/Sepsis
ARF/MOSF
0
7
under $11k
41
68,870
47,045.5
55,787.3125
26
white
32.796875
71
0.289978
0.179993
2
0
0
no
0.5
0.1
dnr after sadm
47
101
6
66
22
36.39844
null
3.599609
0.899902
2
141
null
123
18
null
null
1
null
1
65
1
76.36395
female
0
73
ARF/MOSF w/Sepsis
ARF/MOSF
1
10
null
0
119,087
79,334.5625
92,289.6875
43.25
white
21
21
0.796997
0.730957
2
0
0
no
0.8
0.8
no dnr
73
56
20.898438
132
36
40
231.40625
1.299805
0.899902
0.799927
143
7.349609
134
15
2,505
null
2
adl>=4 (>=5 if sur)
2
890
0
72.57794
female
0
5
MOSF w/Malig
ARF/MOSF
3
10
under $11k
0
6,049
4,106
4,960.94922
18
white
29.097656
29
0.484985
0.365967
1
1
0
metastatic
0.5
0.3
dnr before sadm
-1
60
14.599609
113
28
38.79688
324
2
3.099609
0.899902
137
7.419922
153
33
3.959961
4
2
adl>=4 (>=5 if sur)
2
379
1
75.30695
female
0
9
ARF/MOSF w/Sepsis
ARF/MOSF
3
13
under $11k
0
9,566
6,663.5625
7,227.83984
11.5
white
28.097656
32
0.694946
0.603882
1
1
0
no
0.9
0.7
no dnr
9
132
14.699219
119
24
36.19531
233.3125
null
null
1
133
7.439453
159
19
2,770
1
2
adl>=4 (>=5 if sur)
2
887
0
69.05695
male
0
13
Cirrhosis
COPD/CHF/Cirrhosis
2
5
under $11k
0
12,084
8,825.9062
10,777.8047
8.5
white
16.898438
31
0.786987
0.657959
1
0
0
no
0.8
0.8
no dnr
13
52
10.599609
173
38
37.5
142
2
1.799805
1.799805
135
7.449219
181
29
2,810
null
0
no(M2 and SIP pres)
0
886
0
41.89697
male
0
18
ARF/MOSF w/Sepsis
ARF/MOSF
2
12
$11-$25k
0
41,054
28,431.0625
32,080.2188
18.333328
white
24.796875
42
0.817993
0.756958
15
0
0
no
0.5
0.5
no dnr
18
85
3.199707
77
20
36.39844
null
2.299805
0.699951
1.199951
135
null
153
38
1,660
0
1
SIP>=30
1
576
1
74.69995
female
1
40
ARF/MOSF w/Sepsis
ARF/MOSF
1
16
null
0
38,627
27,789.3906
28,880.125
14.5
white
18.5
36
0.8479
0.795898
1
0
0
no
0.1
0.1
dnr after sadm
1
126
11.699219
111
29
36.19531
162.84375
3.599609
0.5
2.099609
136
7.449219
280
41
1.019775
null
4
<2 mo. follow-up
4
40
1
42.13599
male
0
13
ARF/MOSF w/Sepsis
ARF/MOSF
2
8
under $11k
0
28,696
18,141.125
21,220.9688
37
white
25.5
48
0.855957
0.805908
1
0
0
no
0.4
0.4
no dnr
13
117
13.199219
124
34
39.09375
150
2.399902
0.699951
1.299805
133
7.399414
204
14
2,510
null
0
no(M2 and SIP pres)
0
885
0
55.737
male
0
7
Colon Cancer
Cancer
1
24
>$50k
0
14,069
9,302.2656
10,124.6328
15
white
9.099609
27
0.908936
0.78894
1
0
0
metastatic
1
0.9
no dnr
7
61
18
116
25
36.59375
266.625
1.699951
1.099854
2.199707
129
7.339844
71
120
1,380
1
null
null
1.166748
812
1
68.50897
male
0
11
Lung Cancer
Cancer
1
5
under $11k
0
16,483
11,302.1797
13,779.1953
14
black
19.898438
21
0.613892
0.29895
2
0
0
metastatic
0.99
0.9
no dnr
11
111
16.5
69
39
38.39844
176
null
null
0.899902
136
7.459961
182
17
1,874
1
0
no(M2 and SIP pres)
0
177
1
55.82498
female
1
6
Cirrhosis
COPD/CHF/Cirrhosis
3
12
under $11k
0
10,498
6,723.6055
7,964.65625
20
black
34.695313
56
0.504883
0.302979
1
1
0
no
0.8
0.6
no dnr
6
115
29.398438
189
10
38.79688
null
3.599609
0.899902
1.699951
141
null
241
87
1,929
null
0
<2 mo. follow-up
0
6
1
38.59799
female
0
25
ARF/MOSF w/Sepsis
ARF/MOSF
2
12
$25-$50k
0
53,366
37,353.7812
43,934.875
23
white
31.898438
83
0.725952
0.640991
9
0
0
no
0.8
0.5
no dnr
25
61
13.5
129
34
38.09375
172
1.5
2.599609
1.599854
136
7.299805
144
37
1,710
null
5
<2 mo. follow-up
5
44
1
68.36694
male
1
11
ARF/MOSF w/Sepsis
ARF/MOSF
2
7
$11-$25k
44
35,077
22,686.0156
28,511.875
48
white
35.5
77
0.336975
0.220978
1
0
0
no
0.8
0.7
dnr after sadm
11
123
10.099609
107
28
38.89844
262.5
2.5
0.599976
0.599976
145
7.429688
168
13
2,575
0
0
<2 mo. follow-up
0
11
1
66.5
male
0
16
ARF/MOSF w/Sepsis
ARF/MOSF
2
12
null
44
29,556
19,580.9375
22,636.875
23
black
26.796875
40
0.594971
0.487
1
0
0
no
0.7
0.7
no dnr
16
64
5.299805
69
20
36.39844
null
4.299805
0.799927
3
142
null
86
45
3,900
null
0
no(M2 and SIP pres)
0
133
1
30.51599
female
1
6
Coma
Coma
0
12
null
0
37,150
23,628.5781
26,607.0156
72
white
31.5
48
0.735962
0.68689
4
0
0
no
0.7
0.8
no dnr
6
73
null
107
20
36.09375
197.125
4.199219
0.899902
1.399902
141
7.449219
89
27
1,475
null
0
<2 mo. follow-up
0
6
1
47.20297
male
1
11
ARF/MOSF w/Sepsis
ARF/MOSF
1
13
under $11k
44
17,934
11,697.0781
13,657.0391
27.5
white
27.898438
44
0.67688
0.581909
1
0
0
no
0.6
0.6
dnr after sadm
2
107
4.199219
138
28
39.39844
204
2.5
0.799927
1.199951
155
7.379883
113
22
2,130
null
7
<2 mo. follow-up
7
11
1
69.05396
female
1
15
CHF
COPD/CHF/Cirrhosis
5
12
$11-$25k
0
12,111
8,669
8,888.65625
12.333328
white
26.398438
39
0.704956
0.543945
1
1
0
yes
0.1
0.08
dnr after sadm
2
67
9.599609
91
34
38.39844
428.5625
2
0.599976
1.099854
133
7.399414
112
13
6,370
null
3
<2 mo. follow-up
3
15
1
39.03897
male
1
24
Cirrhosis
COPD/CHF/Cirrhosis
3
12
$11-$25k
0
98,885
0
0
59.666657
black
26.5
50
0.771973
0.636963
5
0
0
no
0.2
0.2
dnr after sadm
23
67
14
118
10
40.29688
185
2.599609
3.299805
1.599854
136
7.429688
78
36
2,261
null
1
<2 mo. follow-up
1
24
1
65.91095
male
0
7
Lung Cancer
Cancer
3
null
null
9
8,834
5,903.5859
7,766.14844
6.5
white
30.296875
36
0.311951
0.056
1
0
0
metastatic
0.4
0.5
no dnr
7
67
5.199219
98
20
35.5
null
2.699707
2.199707
2.599609
140
null
165
62
1,415
null
null
<2 mo. follow-up
4.546875
10
1
72.07098
male
1
44
ARF/MOSF w/Sepsis
ARF/MOSF
3
10
null
0
116,999
73,644.9375
85,335.9375
49.25
black
21.898438
39
0.730957
0.647949
4
0
0
yes
0.8
0.6
dnr after sadm
32
54
8.298828
29
16
36.09375
259.25
null
0.599976
3.099609
129
7.30957
158
69
1,575
null
6
<2 mo. follow-up
6
44
1
74.81696
male
1
7
Coma
Coma
2
12
$11-$25k
44
51,614
33,735.75
38,089.125
30
white
35.398438
86
0.040993
0.019997
12
0
0
no
0
0
dnr after sadm
4
61
4.699219
100
20
38
null
2.5
5.099609
1
135
null
176
31
900
null
5
<2 mo. follow-up
5
7
1
77.89697
male
0
40
ARF/MOSF w/Sepsis
ARF/MOSF
4
8
under $11k
0
78,090
51,049.0312
58,442.75
39
white
40.898438
77
0.250977
0.146973
1
1
0
yes
0.7
0.5
no dnr
40
143
0.069992
150
32
39.19531
124.28125
2.799805
3.399902
1.899902
139
7.349609
198
28
4,610
null
1
no(M2 and SIP pres)
1
100
1
52.94498
female
0
4
COPD
COPD/CHF/Cirrhosis
3
12
$25-$50k
0
3,607
2,301.6797
2,400.04883
20
white
29.796875
30
0.80896
0.690918
1
0
0
no
0.8
0.8
dnr after sadm
1
48
2.599609
105
12
38.09375
68
1.899902
1.799805
0.599976
136
7.419922
102
17
1,158
6
null
SIP>=30
4.527344
873
0
67.85797
male
0
24
ARF/MOSF w/Sepsis
ARF/MOSF
3
14
$25-$50k
0
39,652
26,462.3906
28,410.7656
23
white
17.597656
41
0.841919
0.78894
1
0
0
yes
0.8
0.8
no dnr
24
65
21.699219
129
28
35.39844
154
2.199707
1.199951
6.199219
138
7.429688
82
119
2,200
0
null
no(M2 and SIP pres)
0.494751
872
0
53.01797
female
0
7
MOSF w/Malig
ARF/MOSF
1
16
>$50k
0
7,959
5,581.6875
6,897.40625
19
white
29.898438
43
0.500977
0.382996
1
0
0
metastatic
0.8
0.6
no dnr
7
56
2.099609
110
20
36.5
null
2
10
0.699951
125
null
93
5
2,475
0
0
no(M2 and SIP pres)
0
871
0
61.43997
male
0
56
ARF/MOSF w/Sepsis
ARF/MOSF
2
null
null
37
180,143
115,483.5
137,696.625
50.75
white
37.59375
80
0.269958
0.162994
1
0
0
yes
null
null
no dnr
56
57
12.5
74
11
36.79688
184
2.399902
2.399902
0.699951
137
7.479492
109
16
2,160
null
null
null
4.064453
62
1
58.20398
male
0
86
ARF/MOSF w/Sepsis
ARF/MOSF
2
14
$11-$25k
0
216,314
140,226.625
164,706.75
59
white
29.597656
68
0.68689
0.594971
1
0
0
yes
0.8
0.8
no dnr
86
114
6.199219
97
20
36.29688
null
3.899902
0.599976
1.199951
141
null
145
10
1,850
null
1
adl>=4 (>=5 if sur)
1
871
0
69.45697
female
0
8
COPD
COPD/CHF/Cirrhosis
0
8
under $11k
0
7,372
5,136.1484
5,995.13672
10.5
white
20.796875
29
0.833984
0.728882
1
0
0
no
0.9
0.7
no dnr
8
127
19
104
36
37.69531
297.125
2.799805
1
0.599976
136
7.399414
101
13
2,881
1
null
no(M2 and SIP pres)
1.166748
706
1
57.53299
female
0
7
COPD
COPD/CHF/Cirrhosis
3
12
under $11k
0
9,775
6,172.2305
6,936.95703
18.5
black
16.699219
29
0.917969
0.860962
1
0
0
no
0.9
0.95
no dnr
7
76
4.799805
73
16
36.09375
371.375
4.199219
1
1.199951
137
7.419922
106
23
1,220
1
2
no(M2 and SIP pres)
2
223
1
50.76797
female
1
3
ARF/MOSF w/Sepsis
ARF/MOSF
0
6
under $11k
0
16,143
9,824.7109
10,884.125
null
white
51.09375
74
0.22998
0.129974
1
0
0
no
0.1
0.1
no dnr
3
65
7.099609
107
24
36
100
3.299805
0.699951
2.5
137
7.369141
114
42
4,150
null
null
<2 mo. follow-up
2.187988
3
1
82.63898
female
1
4
Coma
Coma
1
7
under $11k
0
18,882
11,802.0625
14,196.7344
64
black
37.898438
87
0.145996
0.094986
1
0
0
no
0.01
0
dnr after sadm
2
66
7.5
96
28
38.09375
null
3.399902
1.599854
1.299805
144
null
81
12
5,872
null
null
<2 mo. follow-up
2.473145
4
1
39.04999
female
0
4
Cirrhosis
COPD/CHF/Cirrhosis
2
12
under $11k
0
3,991
2,759.334
3,354.55859
11
white
25.296875
38
0.824951
0.714966
1
0
0
no
0.8
0.8
no dnr
4
67
5.599609
58
16
36.29688
null
3.899902
1.199951
1.699951
131
null
179
38
1,580
0
0
<2 mo. follow-up
0
39
1
67.25299
male
0
11
Lung Cancer
Cancer
2
null
null
0
12,915
8,760.2344
12,108.2891
18
white
43.398438
52
0.048996
0.001
1
0
0
metastatic
0.5
0.2
dnr after sadm
5
129
10.199219
146
38
36.79688
436
null
null
1.299805
141
7.419922
119
27
820
null
null
<2 mo. follow-up
4.027344
24
1
63.99698
male
0
11
ARF/MOSF w/Sepsis
ARF/MOSF
0
8
$25-$50k
0
22,779
14,968.2656
17,315.8281
33
white
22.699219
37
0.827881
0.769897
1
0
0
no
0.5
0.6
no dnr
11
76
null
70
22
36.59375
null
null
null
1.099854
141
null
95
20
null
5
6
SIP>=30
6
867
0
53.21298
female
0
26
ARF/MOSF w/Sepsis
ARF/MOSF
0
8
under $11k
26
72,955
48,619.0938
54,370.5625
28
white
21.398438
14
0.778931
0.706909
6
0
0
no
0.8
0.8
no dnr
26
116
16.5
122
9
36.09375
172.5
3.099609
0.899902
0.699951
145
7.489258
267
18
3,717
null
0
null
0
864
0
41.67599
male
0
3
Lung Cancer
Cancer
3
10
under $11k
0
2,901
1,967.1094
2,331.83984
null
black
9.199219
5
0.863892
0.695923
1
0
0
metastatic
0.8
0.6
no dnr
3
74
12.298828
98
20
38.59375
null
2.099609
27.796875
1.099854
129
null
80
6
null
0
0
no(M2 and SIP pres)
0
208
1
62.15198
female
0
4
CHF
COPD/CHF/Cirrhosis
4
9
under $11k
0
4,001
2,693.3906
3,206.91992
14
white
18.796875
23
0.850952
0.753906
1
1
0
yes
0.99
0.85
no dnr
4
69
5.799805
111
8
37.69531
66
2.799805
0.899902
1
133
7.519531
132
18
2,585
0
1
no(M2 and SIP pres)
1
331
1
61.37198
male
1
4
Coma
Coma
0
17
under $11k
100
10,455
5,621.2656
7,498.19922
48
white
29.5
58
0.107986
0.065994
1
0
0
no
0.01
0.01
dnr after sadm
2
76
13.5
96
24
36.39844
null
1.699951
0.699951
2.299805
139
null
129
22
1,750
null
0
<2 mo. follow-up
0
4
1
78.74298
female
1
30
MOSF w/Malig
ARF/MOSF
1
9
$11-$25k
0
80,556
51,749.7812
70,531.0625
29.5
white
21.5
50
0.667969
0.570923
1
0
0
metastatic
0.1
0.01
no dnr
30
85
28.699219
64
20
37.69531
null
3.799805
0.699951
1
130
null
76
6
1,875
1
null
<2 mo. follow-up
1.166748
30
1
23.493
female
1
4
Coma
Coma
0
12
under $11k
100
13,030
8,057.0117
8,885.73438
53
white
87.5
87
0
0
1
0
0
no
0.01
0.01
dnr after sadm
2
69
16.199219
64
24
36.59375
319
null
null
0.599976
143
7.379883
90
11
null
null
0
<2 mo. follow-up
0
4
1
69.91895
male
0
9
COPD
COPD/CHF/Cirrhosis
2
5
$11-$25k
0
12,092
8,069.5352
8,337.34375
10.5
white
18
27
0.863892
0.774902
1
0
0
no
0.9
0.9
no dnr
9
106
22.199219
122
20
36.59375
507.375
2.099609
1.199951
0.899902
137
7.479492
203
17
2,800
0
0
no(M2 and SIP pres)
0
859
0
41.16599
male
0
15
ARF/MOSF w/Sepsis
ARF/MOSF
4
10
under $11k
9
34,917
24,943.7812
28,346.2188
19
black
27.296875
71
0.78894
0.718994
4
0
0
no
0.7
0.7
no dnr
15
174
7.599609
116
40
38.69531
263.3125
2.599609
0.5
0.599976
136
7.479492
368
15
1,807
1
0
null
0
66
1
41.29199
male
0
16
Colon Cancer
Cancer
1
12
under $11k
0
19,689
13,671.9922
15,415.2266
14.666664
white
15.898438
15
0.866943
0.702881
1
0
0
metastatic
0.5
0.2
no dnr
16
64
12.5
67
35
36.89844
250
null
null
0.699951
134
7.479492
191
22
2,258
5
1
SIP>=30
1
75
1
86.36298
female
0
30
COPD
COPD/CHF/Cirrhosis
3
12
under $11k
0
58,245
31,631.7969
38,247.9062
20.75
white
17.097656
20
0.770996
0.635986
2
0
0
no
0.8
0.7
dnr before sadm
-1
84
8.199219
79
32
39.09375
null
2.5
0.899902
0.899902
127
null
113
13
1,550
1
4
no(M2 and SIP pres)
4
857
0
68.36694
male
1
4
COPD
COPD/CHF/Cirrhosis
5
null
null
61
3,360
2,318.0449
2,758.04883
20
white
23.199219
45
0.437988
0.237
1
1
0
metastatic
null
null
dnr after sadm
1
105
6.5
99
28
35.69531
210
null
null
1.899902
126
7.239258
115
38
1,893
null
null
<2 mo. follow-up
5.375
4
1
55.047
male
0
58
ARF/MOSF w/Sepsis
ARF/MOSF
0
12
$25-$50k
0
156,289
106,187.125
111,966.688
47
white
23.097656
32
0.787964
0.718994
34
0
0
no
0.85
0.85
no dnr
58
111
16.199219
136
12
35.89844
130
2
0.599976
1.899902
133
7.379883
73
61
2,790
null
0
SIP>=30
0
857
0
77.91394
female
0
13
MOSF w/Malig
ARF/MOSF
1
14
under $11k
9
27,049
18,148.6719
20,320.8594
30
black
21.097656
37
0.619995
0.514893
2
0
0
metastatic
0.85
0.85
no dnr
13
133
22.097656
141
42
36.69531
186.65625
3.299805
0.599976
0.699951
125
7.399414
159
16
1,316
0
1
no(M2 and SIP pres)
1
856
0
75.05499
male
1
33
ARF/MOSF w/Sepsis
ARF/MOSF
2
12
null
26
82,102
51,896.9375
60,446.4688
48.25
white
26
29
0.640991
0.539917
1
0
0
no
0.8
0.7
no dnr
33
125
25.796875
131
26
36.69531
400
2.199707
5.199219
2.599609
146
7.299805
191
87
4,825
null
5
<2 mo. follow-up
5
33
1
58.82498
female
0
20
ARF/MOSF w/Sepsis
ARF/MOSF
4
12
under $11k
0
44,069
28,972.2031
34,253.4688
35.333313
white
32.09375
76
0.691895
0.600952
1
0
0
no
0.7
0.9
no dnr
20
61
18.199219
108
10
39
234
null
null
0.599976
137
7.519531
116
9
3,299
null
5
null
5
853
0
76.61298
male
0
6
CHF
COPD/CHF/Cirrhosis
3
11
under $11k
0
5,398
3,957.8242
3,586.74805
17
white
23.296875
45
0.777954
0.645996
1
1
0
no
0.75
0.5
no dnr
6
109
1.699951
63
20
35.5
null
2.5
0.5
1.599854
130
null
157
14
700
1
null
<2 mo. follow-up
1.166748
57
1
44.05499
male
0
9
CHF
COPD/CHF/Cirrhosis
2
12
under $11k
0
7,828
5,585.0234
7,064.72656
8.5
white
12
0
0.951904
0.918945
1
0
0
no
1
0.95
no dnr
9
73
16.898438
70
16
35.89844
112.23438
3.099609
0.599976
1.199951
129
7.479492
415
28
2,500
0
null
no(M2 and SIP pres)
0.494751
602
1
73.79895
female
0
9
CHF
COPD/CHF/Cirrhosis
3
null
under $11k
0
12,704
7,072.0625
8,324.51562
12.5
white
16.699219
31
0.870972
0.785889
1
0
0
no
0.9
0.7
no dnr
9
73
8.798828
76
20
36.19531
342.8125
2
1.699951
0.799927
133
7.429688
127
20
2,730
2
0
no(M2 and SIP pres)
0
849
0
60.04898
female
0
7
COPD
COPD/CHF/Cirrhosis
2
12
under $11k
0
5,874
4,007.1875
5,133.14844
8
white
25.398438
22
0.825928
0.716919
1
0
0
no
0.8
0.6
no dnr
7
73
12.599609
114
26
38.5
null
2.299805
3.599609
0.699951
134
null
96
17
1,840
3
5
<2 mo. follow-up
5
14
1
34.59299
male
0
9
COPD
COPD/CHF/Cirrhosis
4
11
under $11k
0
10,607
7,043.9961
8,404.83594
11.5
black
19.5
23
0.951904
0.918945
1
0
0
no
1
1
no dnr
9
61
6.599609
63
10
36.29688
195
3.399902
0.599976
0.799927
140
7.129883
124
9
2,067
1
null
null
1.166748
849
0
60.81299
male
0
51
ARF/MOSF w/Sepsis
ARF/MOSF
1
10
$25-$50k
0
139,666
90,593.75
106,514.5
57.25
white
36.09375
72
0.589966
0.480957
1
0
0
no
0.75
0.75
no dnr
51
64
13.798828
100
26
39
136
2.399902
0.799927
1.299805
134
7.529297
211
9
4,660
null
7
adl>=4 (>=5 if sur)
7
847
0
38.78198
male
0
3
Cirrhosis
COPD/CHF/Cirrhosis
2
11
under $11k
0
2,783
1,907.6865
2,221.56836
null
white
18.398438
13
0.896973
0.826904
1
0
0
no
1
0.95
no dnr
3
110
13.199219
122
24
38.79688
null
4.599609
1
1.199951
132
null
159
6
1,250
0
null
null
0.494751
846
0
63.228
male
1
6
MOSF w/Malig
ARF/MOSF
1
12
under $11k
9
13,880
9,691.0312
12,533.3828
15
white
41
72
0.122986
0.054993
8
0
0
yes
0.2
0.1
dnr after sadm
2
95
7.799805
110
22
38.69531
251.40625
null
null
1.5
132
7.399414
193
17
1,210
null
1
<2 mo. follow-up
1
6
1
38.69397
male
0
56
ARF/MOSF w/Sepsis
ARF/MOSF
0
11
under $11k
37
105,673
71,900.75
79,940.25
36.75
white
24
42
0.759888
0.682983
6
0
0
no
0.7
0.7
no dnr
56
101
6.5
170
28
36.69531
null
2.899902
20.898438
0.399963
132
null
327
15
null
null
2
no(M2 and SIP pres)
2
845
0
57.599
male
0
14
ARF/MOSF w/Sepsis
ARF/MOSF
2
9
null
0
23,119
15,648.1562
16,925.1094
19.333328
hispanic
19.898438
39
0.875
0.830933
1
0
0
no
0.95
0.95
no dnr
14
78
27.898438
120
10
35.5
595.125
1.599854
0.399963
3.699707
135
7.449219
89
40
0
null
0
no(M2 and SIP pres)
0
845
0
69.67798
male
0
3
CHF
COPD/CHF/Cirrhosis
3
12
$11-$25k
0
1,684
1,282.1348
1,205.17969
null
white
18.5
20
0.863892
0.775879
1
0
0
no
0.8
0.8
no dnr
3
60
15.599609
122
52
38.09375
140
1.899902
1.199951
4.899414
138
7.389648
160
37
526
6
6
no(M2 and SIP pres)
6
750
1
57.04898
male
1
19
Coma
Coma
0
8
under $11k
0
56,392
36,381.0312
42,558.75
57.333313
white
24.296875
31
0.735962
0.68689
1
0
0
no
0.3
0.2
dnr after sadm
17
138
26.796875
72
24
35
390.4375
2
5.299805
1.399902
152
7.40918
173
20
2,800
null
0
<2 mo. follow-up
0
19
1
76.66498
male
0
20
ARF/MOSF w/Sepsis
ARF/MOSF
3
9
null
0
43,677
29,397.1719
32,307.4062
30.333328
white
25.296875
33
0.68396
0.589966
7
1
0
no
0.8
0.8
no dnr
20
128
28.097656
147
0
38.5
163.25
null
null
0.599976
134
7.379883
101
13
3,000
null
3
no(M2 and SIP pres)
3
278
1
56.95798
male
0
38
ARF/MOSF w/Sepsis
ARF/MOSF
3
null
under $11k
9
43,875
30,696.6875
35,997.125
13.5
black
25.296875
21
0.778931
0.706909
2
0
0
no
0.8
0.5
no dnr
38
106
15.199219
121
32
37.79688
325
2.699707
1.299805
1.799805
161
7.329102
98
24
3,150
null
1
no(M2 and SIP pres)
1
674
1
68.94696
male
0
17
MOSF w/Malig
ARF/MOSF
2
8
under $11k
0
22,022
15,748.1641
21,591.625
17.333328
black
18.097656
29
0.708984
0.620972
4
0
0
metastatic
0.9
0.8
no dnr
17
109
11.099609
100
32
35.19531
null
3
1.199951
1.199951
134
null
197
21
300
3
2
<2 mo. follow-up
2
58
1
70.02899
female
0
6
CHF
COPD/CHF/Cirrhosis
3
12
under $11k
0
5,310
3,739.8125
4,027.36914
8
white
10.699219
19
0.924927
0.872925
1
1
0
no
0.95
0.9
no dnr
6
125
6
120
8
38.19531
205.6875
1.399902
5
0.699951
129
7.539062
163
21
2,174
0
0
no(M2 and SIP pres)
0
839
0
39.29898
male
0
4
Cirrhosis
COPD/CHF/Cirrhosis
4
8
under $11k
0
8,162
5,345.1914
6,326.28906
15
white
19.699219
18
0.875
0.791992
2
0
0
no
0.2
0.05
no dnr
4
66
13.099609
48
20
34.79688
null
2.799805
0.299988
1.699951
138
null
83
32
null
0
0
no(M2 and SIP pres)
0
837
0
63.13998
male
0
9
COPD
COPD/CHF/Cirrhosis
4
11
under $11k
0
8,050
5,557.668
6,649.9375
9
white
26.597656
36
0.791992
0.664917
1
1
0
no
1
1
no dnr
9
69
14
75
22
37.79688
142.5
2
1.199951
1.299805
132
7.509766
511
32
5,660
3
null
SIP>=30
2.510742
752
1
65.69196
male
0
25
ARF/MOSF w/Sepsis
ARF/MOSF
2
18
null
0
54,606
36,313.7812
40,016.8125
24.25
white
21.296875
30
0.768921
0.694946
4
0
0
yes
0.75
0.6
no dnr
25
53
13.5
114
12
35.39844
226.65625
1.799805
4.099609
2.5
134
7.419922
194
30
362
null
0
no(M2 and SIP pres)
0
253
1
58.23398
female
0
46
ARF/MOSF w/Sepsis
ARF/MOSF
2
12
null
0
147,887
91,126.9375
104,032.562
33.75
white
24.898438
48
0.723999
0.638916
6
1
0
yes
0.4
0.2
no dnr
46
53
16.296875
63
10
35
132
2.299805
0.599976
8.199219
125
7.299805
152
124
290
null
0
no(M2 and SIP pres)
0
626
1
76.22998
female
1
5
Coma
Coma
1
11
$11-$25k
94
10,842
6,858.332
8,003.27734
31
white
26.5
40
0.087997
0.050995
1
0
0
no
0
0
dnr after sadm
2
61
16.398438
72
22
36.29688
107.5
2.699707
0.399963
0.599976
139
7.379883
155
12
1,615
null
7
<2 mo. follow-up
7
5
1
34.49399
female
0
9
ARF/MOSF w/Sepsis
ARF/MOSF
1
10
under $11k
0
21,510
13,542.9688
15,778.5
22.5
black
29.796875
31
0.826904
0.767944
1
0
0
no
0.9
0.9
no dnr
9
72
11.099609
96
24
38.89844
303.6875
2.199707
0.899902
1
133
7.489258
114
21
3.519531
null
0
no(M2 and SIP pres)
0
836
0
72.62097
female
1
9
ARF/MOSF w/Sepsis
ARF/MOSF
0
12
under $11k
0
93,984
60,547.6562
74,304.75
64
white
38
71
0.34198
0.225983
16
0
0
no
0.3
0.3
no dnr
9
64
0.399963
126
20
38.89844
null
null
null
1.599854
135
null
180
12
4,400
null
1
<2 mo. follow-up
1
9
1
83.66595
male
1
23
Coma
Coma
3
null
null
0
76,277
44,498.9062
53,890.25
27.666656
white
23.597656
58
0.437988
0.363953
11
0
0
no
0.01
0.01
dnr after sadm
21
68
19
140
40
38.59375
150
3
8
2.099609
136
7.399414
96
94
4,435
null
0
<2 mo. follow-up
0
23
1
65.71698
female
1
41
ARF/MOSF w/Sepsis
ARF/MOSF
1
null
under $11k
0
152,366
107,529.938
124,863
58.5
white
35.195313
49
0.50293
0.385986
7
0
0
no
0.6
0.6
dnr after sadm
41
55
14.398438
107
13
37.69531
154
1.399902
1.199951
1.599854
136
7.349609
402
46
1,577
null
0
<2 mo. follow-up
0
41
1
57.88098
female
1
103
ARF/MOSF w/Sepsis
ARF/MOSF
1
14
under $11k
0
231,688
148,618.375
171,990.625
42.25
white
28.398438
28
0.748901
0.669922
2
0
0
no
0.5
0.1
dnr after sadm
92
83
11.5
110
20
36.59375
268
3.399902
0.599976
0.899902
149
7.419922
113
21
550
0
1
SIP>=30
1
103
1
55.784
male
0
9
Lung Cancer
Cancer
3
9
$11-$25k
0
9,178
6,278.0234
8,268.85938
14
white
30.097656
22
0.399963
0.102997
1
0
0
metastatic
0.6
0.4
no dnr
9
146
null
71
39
36.5
165
4.199219
1.5
0.899902
143
7.339844
135
14
4,078
1
1
no(M2 and SIP pres)
1
130
1
23.452
male
0
6
ARF/MOSF w/Sepsis
ARF/MOSF
3
10
under $11k
0
8,584
5,815.5508
6,852.29688
38
hispanic
22.597656
43
0.917969
0.887939
1
1
0
no
0.95
0.9
no dnr
6
38
27.097656
138
38
35.39844
39
2.899902
1.099854
1.199951
134
7.319336
393
16
851
1
null
SIP>=30
1.166748
832
0
62.77298
male
0
22
ARF/MOSF w/Sepsis
ARF/MOSF
2
16
under $11k
0
35,988
22,787.0312
26,705.5781
21.333328
white
23.597656
32
0.819946
0.758911
1
0
0
no
0.6
0.6
no dnr
22
58
39.09375
130
10
39.69531
180
2.5
4.199219
4
147
7.399414
236
65
83
null
null
SIP>=30
2.598633
831
0
60.94699
male
0
9
Lung Cancer
Cancer
2
3
under $11k
0
10,915
7,250.5625
9,002.85938
15
white
24.296875
18
0.547974
0.224976
1
0
0
metastatic
0.6
0.5
no dnr
9
70
2.399902
104
20
37.59375
null
2.299805
7
0.5
133
null
78
2
950
2
4
<2 mo. follow-up
4
21
1
66.5
male
0
3
Lung Cancer
Cancer
1
14
$25-$50k
0
3,819
2,507.5723
2,884.60938
13
white
10.599609
6
0.812988
0.5979
1
0
0
metastatic
0.7
0.5
no dnr
3
56
4.699219
101
20
34.5
null
2.399902
5.399414
0.799927
131
null
139
9
675
2
null
no(M2 and SIP pres)
1.838867
269
1
59.57797
female
0
9
ARF/MOSF w/Sepsis
ARF/MOSF
1
11
under $11k
0
27,295
17,937.1875
19,045.1719
25
white
28.898438
25
0.564941
0.452942
5
0
0
metastatic
0.5
0.4
no dnr
9
133
11.798828
100
10
35
257.125
2.399902
0.399963
1.5
142
7.439453
82
40
5,210
6
6
no(M2 and SIP pres)
6
829
0
81.55194
female
0
3
COPD
COPD/CHF/Cirrhosis
3
7
under $11k
0
4,090
2,069.9492
2,634.22852
null
white
14.099609
28
0.851929
0.755981
1
0
0
no
null
null
no dnr
3
126
10.798828
67
22
38.09375
185
4
1.099854
0.5
133
7.379883
105
7
3,980
1
1
no(M2 and SIP pres)
1
828
0
44.35599
male
1
4
ARF/MOSF w/Sepsis
ARF/MOSF
2
9
under $11k
100
14,176
8,502.6875
9,937.72656
63
white
62.195313
129
0
0
1
0
0
no
0
0
dnr after sadm
4
89
3.599609
60
20
37
null
4
0.399963
1.199951
136
null
122
9
null
null
5
<2 mo. follow-up
5
4
1
88.77997
male
1
5
ARF/MOSF w/Sepsis
ARF/MOSF
0
12
$11-$25k
44
22,140
14,377.9844
16,881.2812
59
white
22.898438
39
0.500977
0.383972
4
0
0
no
null
null
no dnr
5
70
7.199219
114
16
36.39844
292
null
null
1.199951
139
7.40918
198
18
1,590
null
5
<2 mo. follow-up
5
5
1
73.37695
male
1
21
Coma
Coma
4
null
null
41
38,297
24,944.0625
29,027.75
35
black
22.097656
42
0.47998
0.407959
1
0
1
no
1
0.5
dnr after sadm
19
49
11.398438
60
18
39.89844
156
2.799805
1.799805
1.299805
137
7.129883
216
23
1,554
null
null
<2 mo. follow-up
5.647461
21
1
74.64996
male
0
14
MOSF w/Malig
ARF/MOSF
1
11
null
0
15,429
10,809.7266
15,069.8984
13.666664
white
29.398438
42
0.529907
0.41394
2
0
0
yes
0.8
0.6
dnr after sadm
1
101
41.796875
74
28
35.89844
219.03125
3.699707
2.399902
0.899902
137
7.519531
97
33
null
0
0
<2 mo. follow-up
0
36
1
82.41998
male
0
20
ARF/MOSF w/Sepsis
ARF/MOSF
2
20
$25-$50k
0
35,216
24,531.2031
27,599.6094
22
white
21.398438
36
0.665894
0.56897
9
0
0
yes
0.65
0.55
no dnr
20
0
14.699219
0
16
37.69531
55
1.699951
0.599976
2.899902
121
7.269531
257
38
null
0
null
adl>=4 (>=5 if sur)
0.494751
823
0
71.48297
female
0
11
Colon Cancer
Cancer
1
12
under $11k
9
8,207
6,213.6523
7,953.60938
8
hispanic
28.597656
19
0.530884
0.208984
1
0
0
metastatic
0.8
0.5
dnr after sadm
7
115
6.399414
114
24
36.69531
216
3.699707
0.599976
1.099854
134
7.349609
103
17
1,325
null
0
adl>=4 (>=5 if sur)
0
93
1
63.25299
male
0
30
Coma
Coma
1
12
null
61
44,181
25,202.3906
31,573.2812
23.5
white
14.5
14
0.672974
0.615967
1
0
0
no
0.05
0
no dnr
30
57
8.699219
109
36
36.19531
173.46875
2.199707
0.599976
12.199219
136
7.379883
115
83
0
null
0
no(M2 and SIP pres)
0
823
0
69.82898
male
0
3
Lung Cancer
Cancer
2
12
$11-$25k
0
2,899
1,931.8603
2,303.25977
8
white
12.5
9
0.778931
0.537964
1
0
0
metastatic
0.9
0.5
no dnr
3
105
4.099609
71
28
37
null
null
null
0.799927
136
null
79
9
null
null
null
no(M2 and SIP pres)
2.416504
225
1
76.04895
female
0
8
CHF
COPD/CHF/Cirrhosis
5
13
under $11k
0
9,818
5,800.0547
7,187.97656
10.5
white
21.898438
44
0.800903
0.678955
1
1
0
no
0.9
0.85
dnr after sadm
2
114
15
69
26
38.69531
304.125
null
null
1.199951
134
7.40918
109
18
2,335
7
5
no(M2 and SIP pres)
5
822
0
68.28198
female
0
10
ARF/MOSF w/Sepsis
ARF/MOSF
4
12
$11-$25k
41
22,189
14,281.4219
16,558.2344
35
white
32.796875
51
0.431946
0.311951
1
1
0
no
0.35
0.25
no dnr
10
114
19.597656
140
28
37.59375
240
2.799805
1.699951
1.5
144
7.119141
199
49
null
null
2
no(M2 and SIP pres)
2
228
1
64.22198
female
0
28
CHF
COPD/CHF/Cirrhosis
7
12
null
9
34,293
22,793.4844
25,882
22.5
white
24.699219
43
0.782959
0.652954
1
1
0
no
0.9
0.8
dnr after sadm
8
109
43.59375
128
8
36.89844
290
1.399902
1.899902
0.799927
135
7.449219
174
18
3,067
0
1
no(M2 and SIP pres)
1
173
1